PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Aug-2025 Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks SYNBIOTIC SE
14-Aug-2025 DOUGLAS Group achieves solid growth and confirms guidance for 2024/25 Douglas AG
14-Aug-2025 Relief Therapeutics Publishes 2025 Half-Year Report Relief Therapeutics Holding SA
13-Aug-2025 Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert® Mainz BioMed N.V.
13-Aug-2025 Medios accelerates growth in the first half of 2025 and significantly increases earnings Medios AG
13-Aug-2025 Straumann Group delivers strong first half and confirms full-year 2025 outlook Straumann Holding AG
13-Aug-2025 Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE
13-Aug-2025 Formycon confirms full-year guidance following business development in line with plan – working capital raised Formycon AG
12-Aug-2025 Trump’s proposed 200-250% tariff on pharma imports to lead to drug shortages and higher prices, says GlobalData GlobalData
12-Aug-2025 Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept Mabylon AG
12-Aug-2025 Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board Gerresheimer AG
12-Aug-2025 Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 Dermapharm Holding SE
12-Aug-2025 SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma AG & Co. KGaA
12-Aug-2025 Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
12-Aug-2025 PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range PolyPeptide Group
11-Aug-2025 Periocream: The Future Commercial Winner for bonyf bonyf NV
11-Aug-2025 Relief Therapeutics Advances Publication of 2025 Half-Year Report Relief Therapeutics Holding SA
11-Aug-2025 Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Nyxoah SA.
11-Aug-2025 Newron notes the publication of new preclinical research suggesting evenamide ameliorates schizophrenia-related dysfunction Newron Pharmaceuticals S.p.A.
08-Aug-2025 Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea Nyxoah SA.